HSBC Holdings
MRNA icon

HSBC Holdings’s Moderna MRNA Stock Holding History

HSBC Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84M Buy
+57,700
New +$2.69M ﹤0.01% 1375
2024
Q2 		– Sell
-33,600
Closed -$3.58M – 3096
2024
Q1 		$3.58M Sell
33,600
-23,600
-41% -$2.38M ﹤0.01% 1226
2023
Q4 		$5.68M Sell
57,200
-6,800
-11% -$572K ﹤0.01% 1107
2023
Q3 		$6.59M Buy
64,000
+26,900
+73% +$3M 0.01% 989
2023
Q2 		$4.54M Buy
37,100
+13,500
+57% +$1.8M ﹤0.01% 1092
2023
Q1 		$3.59M Hold
23,600
– – ﹤0.01% 1252
2022
Q4 		$4.16M Hold
23,600
– – ﹤0.01% 1338
2022
Q3 		$2.84M Buy
+23,600
New +$3.58M ﹤0.01% 1405

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings's MRNA Position: Q1 2026 in Review

HSBC Holdings reduced its Moderna (MRNA) stake by 23% in Q1 2026, selling an estimated $6.92M and leaving 490,088 shares worth $24.6M. The position accounts for 0.01% of the portfolio, ranked #686.

HSBC Holdings first reported a position in MRNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $141M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • HSBC Holdings held 490,088 shares of Moderna worth $24.6M as of Q1 2026.
  • HSBC Holdings sold 148,282 Moderna shares in Q1 2026, an estimated $6.92M.
  • Moderna made up 0.01% of HSBC Holdings's portfolio in Q1 2026, its #686 holding.
  • HSBC Holdings first reported a position in Moderna in Q1 2020 and has held it in 25 quarters since.
  • HSBC Holdings's Moderna position peaked at $141M in Q3 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.